Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mouth Diseases | 6 | 2022 | 39 | 1.680 |
Why?
|
| Mouth Neoplasms | 12 | 2020 | 206 | 1.510 |
Why?
|
| Mouth Mucosa | 12 | 2022 | 51 | 1.480 |
Why?
|
| Oral Ulcer | 6 | 2022 | 22 | 1.290 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2021 | 94 | 1.170 |
Why?
|
| Gingival Neoplasms | 6 | 2011 | 13 | 1.120 |
Why?
|
| Carcinoma, Squamous Cell | 11 | 2015 | 629 | 0.920 |
Why?
|
| Diagnosis, Differential | 26 | 2015 | 1140 | 0.840 |
Why?
|
| Glossitis, Benign Migratory | 1 | 2022 | 1 | 0.830 |
Why?
|
| Tongue, Hairy | 1 | 2022 | 1 | 0.830 |
Why?
|
| Stomatitis, Aphthous | 1 | 2022 | 2 | 0.830 |
Why?
|
| Monckeberg Medial Calcific Sclerosis | 1 | 2021 | 2 | 0.790 |
Why?
|
| Gingival Diseases | 5 | 2010 | 22 | 0.760 |
Why?
|
| Arteriosclerosis | 1 | 2021 | 137 | 0.760 |
Why?
|
| Calcinosis | 1 | 2021 | 241 | 0.690 |
Why?
|
| Salivary Gland Neoplasms | 5 | 2014 | 40 | 0.670 |
Why?
|
| Odontogenic Cysts | 6 | 2007 | 13 | 0.670 |
Why?
|
| Palatal Neoplasms | 5 | 2006 | 10 | 0.640 |
Why?
|
| Mandibular Diseases | 9 | 2011 | 28 | 0.630 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 194 | 0.620 |
Why?
|
| Precancerous Conditions | 5 | 2020 | 74 | 0.580 |
Why?
|
| Lip Neoplasms | 4 | 2011 | 12 | 0.580 |
Why?
|
| Palate, Hard | 2 | 2006 | 7 | 0.550 |
Why?
|
| Mandibular Neoplasms | 6 | 2011 | 16 | 0.530 |
Why?
|
| Humans | 78 | 2022 | 68618 | 0.490 |
Why?
|
| Mucous Membrane | 1 | 2014 | 66 | 0.480 |
Why?
|
| Fibroma | 3 | 2011 | 20 | 0.480 |
Why?
|
| Leukoplakia, Oral | 3 | 2007 | 12 | 0.480 |
Why?
|
| Maxillary Diseases | 4 | 2007 | 13 | 0.460 |
Why?
|
| Tongue Diseases | 3 | 2010 | 14 | 0.450 |
Why?
|
| Mucocele | 2 | 2010 | 20 | 0.450 |
Why?
|
| Carcinoma in Situ | 2 | 2020 | 47 | 0.450 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 475 | 0.430 |
Why?
|
| Epithelial Cells | 1 | 2014 | 431 | 0.400 |
Why?
|
| Rhabdomyosarcoma | 2 | 2012 | 36 | 0.400 |
Why?
|
| Vascular Neoplasms | 1 | 2011 | 15 | 0.390 |
Why?
|
| Fasciitis | 1 | 2011 | 30 | 0.390 |
Why?
|
| Male | 39 | 2022 | 37321 | 0.370 |
Why?
|
| Adult | 35 | 2020 | 21403 | 0.370 |
Why?
|
| Maxillary Neoplasms | 4 | 2015 | 12 | 0.360 |
Why?
|
| Female | 48 | 2021 | 38074 | 0.360 |
Why?
|
| Choristoma | 1 | 2010 | 20 | 0.350 |
Why?
|
| Erythroplasia | 2 | 2006 | 6 | 0.340 |
Why?
|
| Aged | 20 | 2022 | 14862 | 0.330 |
Why?
|
| Odontogenic Tumors | 5 | 2014 | 9 | 0.330 |
Why?
|
| Plasminogen | 1 | 2008 | 28 | 0.320 |
Why?
|
| Genital Diseases, Female | 1 | 2008 | 23 | 0.320 |
Why?
|
| Peritoneum | 1 | 2008 | 27 | 0.310 |
Why?
|
| Skin Diseases | 1 | 2010 | 122 | 0.310 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2008 | 30 | 0.310 |
Why?
|
| Pathology, Oral | 1 | 2007 | 2 | 0.310 |
Why?
|
| Alveolar Process | 1 | 2007 | 18 | 0.290 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2005 | 3 | 0.270 |
Why?
|
| Xanthomatosis | 3 | 1996 | 7 | 0.250 |
Why?
|
| Jaw Neoplasms | 2 | 2014 | 4 | 0.240 |
Why?
|
| Aged, 80 and over | 9 | 2014 | 4848 | 0.230 |
Why?
|
| Warts | 2 | 2007 | 6 | 0.210 |
Why?
|
| Melanosis | 1 | 2002 | 4 | 0.210 |
Why?
|
| Gingival Hyperplasia | 2 | 1994 | 4 | 0.200 |
Why?
|
| Inflammation | 1 | 2008 | 1030 | 0.200 |
Why?
|
| Adolescent | 10 | 2020 | 8912 | 0.200 |
Why?
|
| Middle Aged | 24 | 2020 | 21147 | 0.200 |
Why?
|
| Radiography, Panoramic | 1 | 2021 | 8 | 0.200 |
Why?
|
| Maxillary Artery | 1 | 2021 | 5 | 0.200 |
Why?
|
| Tunica Media | 1 | 2021 | 33 | 0.200 |
Why?
|
| Gingival Hemorrhage | 1 | 2001 | 10 | 0.190 |
Why?
|
| Curriculum | 2 | 2021 | 575 | 0.190 |
Why?
|
| Ameloblastoma | 2 | 2014 | 5 | 0.190 |
Why?
|
| Lip Diseases | 2 | 2010 | 8 | 0.180 |
Why?
|
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 2020 | 1 | 0.180 |
Why?
|
| Rare Diseases | 1 | 2020 | 41 | 0.180 |
Why?
|
| Neurilemmoma | 1 | 2020 | 26 | 0.180 |
Why?
|
| Carcinoma | 2 | 2014 | 215 | 0.170 |
Why?
|
| Sebaceous Glands | 2 | 2010 | 8 | 0.160 |
Why?
|
| Periodontal Cyst | 4 | 2011 | 4 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 3 | 2012 | 561 | 0.160 |
Why?
|
| Adenoma, Pleomorphic | 3 | 2014 | 10 | 0.160 |
Why?
|
| Erythema | 2 | 2007 | 18 | 0.150 |
Why?
|
| Students, Dental | 2 | 2007 | 49 | 0.140 |
Why?
|
| Young Adult | 3 | 2014 | 5717 | 0.140 |
Why?
|
| Child | 6 | 2020 | 6405 | 0.140 |
Why?
|
| Incidence | 1 | 2021 | 1603 | 0.140 |
Why?
|
| Education, Dental | 2 | 2007 | 63 | 0.140 |
Why?
|
| Radiography | 6 | 2011 | 572 | 0.130 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 1 | 1995 | 4 | 0.130 |
Why?
|
| Periodontium | 1 | 1995 | 11 | 0.130 |
Why?
|
| Neuroectodermal Tumor, Melanotic | 1 | 2015 | 4 | 0.130 |
Why?
|
| Morbidity | 1 | 2015 | 130 | 0.120 |
Why?
|
| Membranes, Artificial | 1 | 1995 | 88 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 843 | 0.120 |
Why?
|
| Prognosis | 4 | 2015 | 2093 | 0.120 |
Why?
|
| Global Health | 1 | 2015 | 136 | 0.120 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2014 | 12 | 0.120 |
Why?
|
| Salivary Glands, Minor | 3 | 1994 | 7 | 0.120 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2014 | 14 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2014 | 89 | 0.120 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 111 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2014 | 7277 | 0.120 |
Why?
|
| Hyalin | 2 | 2012 | 8 | 0.120 |
Why?
|
| Calcium Channel Blockers | 1 | 1994 | 138 | 0.120 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 20 | 0.120 |
Why?
|
| Mandible | 3 | 2006 | 53 | 0.120 |
Why?
|
| Metaplasia | 2 | 2010 | 27 | 0.110 |
Why?
|
| Adenoma | 3 | 2006 | 132 | 0.110 |
Why?
|
| Jaw Diseases | 2 | 2007 | 7 | 0.110 |
Why?
|
| Cheek | 2 | 2010 | 11 | 0.110 |
Why?
|
| Palate | 2 | 2010 | 14 | 0.110 |
Why?
|
| Gingiva | 2 | 2011 | 34 | 0.110 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 508 | 0.110 |
Why?
|
| Mouth Floor | 2 | 2010 | 9 | 0.100 |
Why?
|
| Risk Factors | 4 | 2007 | 5731 | 0.100 |
Why?
|
| Age Factors | 3 | 2010 | 1864 | 0.100 |
Why?
|
| Granular Cell Tumor | 2 | 2007 | 9 | 0.100 |
Why?
|
| Clinical Competence | 2 | 2007 | 657 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 19 | 0.100 |
Why?
|
| Hypopharyngeal Neoplasms | 1 | 2011 | 10 | 0.100 |
Why?
|
| Neurofibroma | 1 | 1991 | 11 | 0.100 |
Why?
|
| Lip | 2 | 2009 | 12 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 47 | 0.100 |
Why?
|
| Sex Factors | 2 | 2010 | 1266 | 0.100 |
Why?
|
| Neurofibromatosis 1 | 1 | 1991 | 39 | 0.100 |
Why?
|
| Autoantigens | 1 | 2011 | 91 | 0.100 |
Why?
|
| Cell Movement | 2 | 2011 | 630 | 0.090 |
Why?
|
| Tooth Erosion | 1 | 2010 | 5 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1465 | 0.090 |
Why?
|
| Bulimia | 1 | 2010 | 72 | 0.090 |
Why?
|
| Color | 1 | 2010 | 50 | 0.090 |
Why?
|
| Rupture | 1 | 2010 | 29 | 0.090 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2010 | 22 | 0.090 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2010 | 24 | 0.090 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2010 | 37 | 0.090 |
Why?
|
| Mycophenolic Acid | 1 | 2010 | 62 | 0.090 |
Why?
|
| Periodontal Diseases | 1 | 2010 | 54 | 0.090 |
Why?
|
| Oxytetracycline | 1 | 1990 | 2 | 0.090 |
Why?
|
| Mouth | 1 | 2010 | 64 | 0.090 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 1990 | 8 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 122 | 0.090 |
Why?
|
| Foreign-Body Reaction | 1 | 1990 | 24 | 0.090 |
Why?
|
| Administration, Topical | 1 | 1990 | 111 | 0.090 |
Why?
|
| Hair Follicle | 1 | 2010 | 37 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2007 | 1174 | 0.080 |
Why?
|
| Collagen | 3 | 1995 | 636 | 0.080 |
Why?
|
| Fibroma, Ossifying | 2 | 2001 | 5 | 0.080 |
Why?
|
| Adenoma, Sweat Gland | 1 | 1988 | 4 | 0.080 |
Why?
|
| Infant | 3 | 2015 | 2891 | 0.080 |
Why?
|
| United States | 1 | 2021 | 7367 | 0.080 |
Why?
|
| Nevus | 1 | 1988 | 17 | 0.080 |
Why?
|
| Salivary Glands | 1 | 1988 | 52 | 0.080 |
Why?
|
| Biopsy | 2 | 2007 | 540 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 1990 | 291 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 318 | 0.080 |
Why?
|
| Jaw Cysts | 1 | 2007 | 2 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1990 | 234 | 0.080 |
Why?
|
| Epithelium | 4 | 2006 | 172 | 0.070 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 2007 | 3 | 0.070 |
Why?
|
| Keratosis | 1 | 2007 | 17 | 0.070 |
Why?
|
| Skin Transplantation | 2 | 1986 | 45 | 0.070 |
Why?
|
| Professional-Patient Relations | 1 | 2007 | 71 | 0.070 |
Why?
|
| Maxilla | 1 | 2007 | 63 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2007 | 141 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 1988 | 249 | 0.070 |
Why?
|
| Cysts | 1 | 2007 | 70 | 0.070 |
Why?
|
| Periodontal Ligament | 1 | 1986 | 16 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 514 | 0.070 |
Why?
|
| Pemphigus | 1 | 2006 | 12 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 132 | 0.070 |
Why?
|
| South Carolina | 2 | 2010 | 2752 | 0.070 |
Why?
|
| Gelsolin | 1 | 2005 | 6 | 0.070 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 29 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2011 | 369 | 0.070 |
Why?
|
| Teaching | 1 | 2007 | 169 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 66 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 102 | 0.060 |
Why?
|
| Communication | 1 | 2007 | 329 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 237 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 756 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2010 | 3187 | 0.060 |
Why?
|
| Papilloma | 1 | 1983 | 8 | 0.060 |
Why?
|
| Health Personnel | 1 | 2007 | 286 | 0.060 |
Why?
|
| Gingivoplasty | 1 | 1983 | 7 | 0.060 |
Why?
|
| Alcohol Drinking | 2 | 2007 | 805 | 0.060 |
Why?
|
| Carcinoma, Verrucous | 1 | 2002 | 5 | 0.050 |
Why?
|
| Skin | 3 | 2020 | 451 | 0.050 |
Why?
|
| Smoking | 2 | 2007 | 1452 | 0.050 |
Why?
|
| Granuloma | 1 | 2001 | 21 | 0.050 |
Why?
|
| Rhabdomyoma | 1 | 1981 | 7 | 0.050 |
Why?
|
| Tobacco | 1 | 2002 | 161 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1981 | 46 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 1981 | 47 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 235 | 0.050 |
Why?
|
| Cattle | 2 | 1995 | 475 | 0.050 |
Why?
|
| Pediatric Dentistry | 1 | 2020 | 3 | 0.040 |
Why?
|
| Brazil | 1 | 2020 | 48 | 0.040 |
Why?
|
| Connective Tissue | 3 | 2006 | 61 | 0.040 |
Why?
|
| Neoplasms | 1 | 2011 | 1667 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 800 | 0.040 |
Why?
|
| Molar, Third | 2 | 2007 | 7 | 0.040 |
Why?
|
| Leiomyoma | 1 | 1979 | 28 | 0.040 |
Why?
|
| Tooth Extraction | 2 | 2007 | 27 | 0.040 |
Why?
|
| Wound Healing | 2 | 1995 | 260 | 0.040 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1997 | 6 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 1997 | 40 | 0.040 |
Why?
|
| Nasal Cavity | 1 | 1997 | 62 | 0.030 |
Why?
|
| Acantholysis | 1 | 1996 | 4 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 951 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 1995 | 92 | 0.030 |
Why?
|
| Pregnancy | 1 | 2001 | 2334 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Direct | 2 | 2006 | 21 | 0.030 |
Why?
|
| Dogs | 1 | 1995 | 490 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 446 | 0.030 |
Why?
|
| Leiomyosarcoma | 1 | 1993 | 17 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 196 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1995 | 1040 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 261 | 0.030 |
Why?
|
| Myogenin | 1 | 2012 | 9 | 0.030 |
Why?
|
| Desmin | 1 | 2012 | 13 | 0.030 |
Why?
|
| Sclerosis | 1 | 2012 | 32 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 76 | 0.030 |
Why?
|
| Recurrence | 2 | 1986 | 948 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2012 | 164 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2011 | 4 | 0.030 |
Why?
|
| Sarcoma | 1 | 2012 | 70 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2011 | 6 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 41 | 0.030 |
Why?
|
| Vimentin | 1 | 2011 | 47 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 100 | 0.020 |
Why?
|
| Neprilysin | 1 | 2011 | 55 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 73 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 237 | 0.020 |
Why?
|
| Orbital Neoplasms | 1 | 1991 | 21 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 145 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 274 | 0.020 |
Why?
|
| Azathioprine | 1 | 2010 | 16 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 2010 | 27 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2010 | 30 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 33 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 36 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 55 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 122 | 0.020 |
Why?
|
| Remission Induction | 1 | 2010 | 111 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 104 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 312 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 3259 | 0.020 |
Why?
|
| Rituximab | 1 | 2010 | 61 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1988 | 351 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Time Factors | 3 | 2007 | 4655 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2011 | 7029 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1990 | 304 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 649 | 0.020 |
Why?
|
| Candidiasis, Oral | 1 | 1988 | 7 | 0.020 |
Why?
|
| Dentin | 1 | 1988 | 14 | 0.020 |
Why?
|
| Toothache | 1 | 2007 | 7 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1038 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.020 |
Why?
|
| Diagnosis, Oral | 1 | 2007 | 14 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 511 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2324 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 753 | 0.020 |
Why?
|
| Parotid Neoplasms | 1 | 1988 | 49 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 756 | 0.020 |
Why?
|
| Tobacco Use Cessation | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.020 |
Why?
|
| Mucins | 1 | 2006 | 22 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 67 | 0.020 |
Why?
|
| Temporomandibular Joint | 1 | 1986 | 18 | 0.020 |
Why?
|
| Dental Cementum | 1 | 1986 | 3 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 116 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2006 | 35 | 0.020 |
Why?
|
| Models, Educational | 1 | 2007 | 67 | 0.020 |
Why?
|
| Cartilage, Articular | 1 | 1986 | 38 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2007 | 144 | 0.020 |
Why?
|
| Problem-Based Learning | 1 | 2007 | 72 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 124 | 0.020 |
Why?
|
| Alveoloplasty | 1 | 1985 | 1 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2007 | 259 | 0.020 |
Why?
|
| Granulation Tissue | 1 | 1985 | 6 | 0.020 |
Why?
|
| Alveolar Ridge Augmentation | 1 | 1985 | 7 | 0.020 |
Why?
|
| Glutaral | 1 | 1985 | 41 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 1985 | 28 | 0.020 |
Why?
|
| Counseling | 1 | 2007 | 280 | 0.020 |
Why?
|
| Animals | 3 | 1995 | 20881 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 532 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2007 | 254 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 397 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2005 | 52 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 954 | 0.020 |
Why?
|
| Pharyngitis | 1 | 2004 | 10 | 0.010 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2004 | 14 | 0.010 |
Why?
|
| Melanocytes | 1 | 1983 | 23 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1983 | 18 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1173 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.010 |
Why?
|
| Oral Surgical Procedures | 1 | 2003 | 15 | 0.010 |
Why?
|
| Ceramides | 1 | 2007 | 578 | 0.010 |
Why?
|
| Microsurgery | 1 | 2003 | 46 | 0.010 |
Why?
|
| Health Education | 1 | 2005 | 279 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 617 | 0.010 |
Why?
|
| Glomus Tumor | 1 | 1981 | 2 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1981 | 29 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 319 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 767 | 0.010 |
Why?
|
| Life Style | 1 | 2003 | 338 | 0.010 |
Why?
|
| Keratins | 1 | 1980 | 48 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 2004 | 297 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1983 | 375 | 0.010 |
Why?
|
| Diet | 1 | 2003 | 514 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 848 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2007 | 1034 | 0.010 |
Why?
|
| Hamartoma | 1 | 1998 | 24 | 0.010 |
Why?
|
| Rats | 1 | 1985 | 5300 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1997 | 30 | 0.010 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 1994 | 4 | 0.010 |
Why?
|
| Thigh | 1 | 1993 | 27 | 0.010 |
Why?
|
| Necrosis | 1 | 1994 | 239 | 0.010 |
Why?
|
| Sex Ratio | 1 | 1993 | 13 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1993 | 99 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1993 | 149 | 0.010 |
Why?
|
| Palliative Care | 1 | 1993 | 271 | 0.010 |
Why?
|
| Cavernous Sinus | 1 | 1991 | 10 | 0.010 |
Why?
|
| Tooth, Deciduous | 1 | 1988 | 6 | 0.000 |
Why?
|
| Tooth Diseases | 1 | 1988 | 6 | 0.000 |
Why?
|
| Candida albicans | 1 | 1988 | 39 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1993 | 2455 | 0.000 |
Why?
|
| Macaca fascicularis | 1 | 1986 | 31 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1991 | 2223 | 0.000 |
Why?
|